Lily Wong Lee Lee
Overview
Explore the profile of Lily Wong Lee Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang B, Li J, Liu L, Du X, Jiang H, Hu J, et al.
Ann Hematol
. 2025 Mar;
PMID: 40063243
The COMMODORE study demonstrated the efficacy and safety of gilteritinib versus salvage chemotherapy (SC) treatment in a predominantly Asian population with relapsed/refractory (R/R) FMS-like tyrosine kinase 3 (FLT3)-mutated() acute myeloid...
2.
Wang J, Jiang B, Li J, Liu L, Du X, Jiang H, et al.
Leukemia
. 2024 Sep;
38(11):2410-2418.
PMID: 39237634
The phase 3 COMMODORE trial evaluated gilteritinib versus salvage chemotherapy (SC) in a predominantly Asian relapsed/refractory (R/R) FLT3-mutated (FLT3) acute myeloid leukemia (AML) patient population. The primary endpoint was overall...
3.
Peffault de Latour R, Roth A, Kulasekararaj A, Han B, Scheinberg P, Maciejewski J, et al.
N Engl J Med
. 2024 Mar;
390(11):994-1008.
PMID: 38477987
Background: Persistent hemolytic anemia and a lack of oral treatments are challenges for patients with paroxysmal nocturnal hemoglobinuria who have received anti-C5 therapy or have not received complement inhibitors. Iptacopan,...
4.
Lee J, Griffin M, Kim J, Lee L, Piatek C, Nishimura J, et al.
Lancet Haematol
. 2023 Nov;
10(12):e955-e965.
PMID: 38030318
Background: Symptoms of anaemia due to clinically significant extravascular haemolysis can affect patients with paroxysmal nocturnal haemoglobinuria (PNH) treated with C5 inhibitors (ravulizumab or eculizumab). The aim of this study...
5.
Lee J, Sicre de Fontbrune F, Lee L, Pessoa V, Gualandro S, Fureder W, et al.
Blood
. 2018 Dec;
133(6):530-539.
PMID: 30510080
Ravulizumab (ALXN1210), a new complement C5 inhibitor, provides immediate, complete, and sustained C5 inhibition. This phase 3, open-label study assessed the noninferiority of ravulizumab to eculizumab in complement inhibitor-naive adults...
6.
Keowmani T, Lee L
Patient Prefer Adherence
. 2016 Mar;
10:205-11.
PMID: 26955264
Purpose: To study the validity and reliability of the Malay version of the Specific Thalassemia Quality of Life Instrument (STQOLI) in Sabah's adult thalassemia patients. Patients And Methods: This cross-sectional...